✦ LIBER ✦

Efficacy and safety of dasatinib versus imatinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP): Subset analysis of the DASISION trial with 2-year follow-up

✍ Scribed by Fujisawa, Shin; Nakamae, Hirohisa; Ogura, Michinori; Ishizawa, Ken-ichi; Taniwaki, Masafumi; Utsunomiya, Atae; Matsue, Kosei; Takamatsu, Yasushi; Usuki, Kensuke; Tanimoto, Mitsune; Ishida, Yoji; Akiyama, Hideki; Onishi, Shintaro

Book ID: 125378981
Publisher: Carden Jennings Publishing
Year: 2013
Tongue: English
Weight: 367 KB
Volume: 99
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-013-1470-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN92 Cost-Effectiveness of Nilotinib Ve

PCN92 Cost-Effectiveness of Nilotinib Versus Imatinib as First-Line Treatment for Newly Diagnosed Patients With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in the Chronic Phase (CML-CP) in Russian Federation

✍ R. Yagudina; A. Kulikov; I. Komarov 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN57 Cost Effectiveness of Nilotinib Ve

PCN57 Cost Effectiveness of Nilotinib Versus Imatinib as First Line Treatment for Newly Diagnosed Hong Kong (HK) Patients With Chronic Phase, Philadelphia Chromosome-Positive (PH+) Chronic Myeloid Leukemia in the Chronic Phase (CML-CP) in Hong Kong

✍ Tse, V.; Liu, H.; Botteman, M.; Mcghee, S.; Lee, V.W.; Lee, K.K. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB